Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 12:10 AM UTC
| NCT Number | NCT06047886 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 21, 2026: Clinical trial NCT06047886 is currently recruiting participants. This phase1 study for aml is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06047886 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06047886 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.